{"id":39984,"date":"2021-05-17T22:01:00","date_gmt":"2021-05-17T22:01:00","guid":{"rendered":"https:\/\/idafoundation.org\/?p=39984"},"modified":"2026-02-23T22:03:02","modified_gmt":"2026-02-23T22:03:02","slug":"invitation-to-bid-itb-on-behalf-of-stop-tb-gdf-3","status":"publish","type":"post","link":"https:\/\/idafoundation.org\/fr\/invitation-to-bid-itb-on-behalf-of-stop-tb-gdf-3\/","title":{"rendered":"Invitation to bid (ITB) on behalf of Stop TB\/GDF"},"content":{"rendered":"

17 May 2021<\/strong> – Geneva, Switzerland – On behalf of Stop TB Partnership\u2019s Global Drug Facility (GDF), IDA Foundation (IDA), the GDF- contracted procurement agent, invites all eligible suppliers to submit bids (ITB) for:<\/p>\n\n\n\n

ITB-IDA\/GDF-FLD\/20<\/strong>21<\/strong>\/001<\/strong>, for Ethambutol 100mg dispersible tablets for the treatment of drug-sensitive forms of tuberculosis.<\/p>\n\n\n\n

The purpose of the ITBs is to select a panel of suppliers who will enter into a long-term agreement with IDA.<\/p>\n\n\n\n

The ITBs are open to bidders whose products have been deemed eligible for inclusion in the tender in compliance with GDF’s Quality Assurance policy and procedures<\/a>. A bid submitted for (a) product(s) for which the bidder has not received regulatory approval status in accordance with the GDF Quality Assurance policy and procedures shall not be considered for the ITB evaluation.<\/p>\n\n\n\n

All bids are subject to the Instructions to Bidders and other provisions, specifications and instructions as contained in this dossier.<\/p>\n\n\n\n

This ITB comprises of the following:<\/p>\n\n\n\n

For ITB\/GDF-FLD\/2021\/001:<\/h3>\n\n\n\n